Yohei Yabuuchi

Yohei Yabuuchi

Auto-generated profile, based on publicly available information

Yohei Yabuuchi

Department of Gastroenterology, Kobe City Medical Center General Hospital, Kobe, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
MYMasao Yoshida
Masao Yoshida
YYYohei Yabuuchi
Yohei Yabuuchi
NKNaomi Kakushima
Naomi Kakushima
MKMotohiko Kato
Motohiko Kato
MIMikitaka Iguchi
Mikitaka Iguchi
JCJapan Duodenal Cancer Guideline Committee
Japan Duodenal Cancer Guideline Committee

Verified
Journal Article
Open access
PDF file
HMHiroyuki Matsubayashi
Hiroyuki Matsubayashi
HIHirotoshi Ishiwatari
Hirotoshi Ishiwatari
KIKenichiro Imai
Kenichiro Imai
YKYoshihiro Kishida
Yoshihiro Kishida
SISayo Ito
Sayo Ito
HOHiroyuki Ono
Hiroyuki Ono
Autoimmune pancreatitis (AIP), a unique subtype of pancreatitis, is often accompanied by systemic inflammatory disorders. AIP is classified into two distinct subtypes on the basis of the histological subtype: immunoglobulin G4 (IgG4)-related lymphoplasmacytic sclerosing pancreatitis (type 1) and idiopathic duct-centric pancreatitis (type 2). Type 1 AIP is often accompanied by systemic lesions, biliary strictures, hepatic inflammatory pseudotumors, interstitial pneumonia and nephritis, dacryoadenitis, and sialadenitis. Type 2 AIP is associated with inflammatory bowel diseases in approximately 30% of cases. Standard therapy for AIP is oral corticosteroid administration. Steroid treatment is generally indicated for symptomatic cases and is exceptionally applied for cases with diagnostic difficulty (diagnostic steroid trial) after a negative workup for malignancy. More than 90% of patients respond to steroid treatment within 1 month, and most within 2 weeks. The steroid response can be confirmed on clinical images (computed tomography, ultrasonography, endoscopic ultrasonography, magnetic resonance imaging, and 18F-fluorodeoxyglucose-positron emission tomography). Hence, the steroid response is included as an optional diagnostic item of AIP. Steroid treatment results in normalization of serological markers, including IgG4. Short- and long-term corticosteroid treatment may induce adverse events, including chronic glycometabolism, obesity, an immunocompromised status against infection, cataracts, glaucoma, osteoporosis, and myopathy. AIP is common in old age and is often associated with diabetes mellitus (33–78%). Thus, there is an argument for corticosteroid therapy in diabetes patients with no symptoms. With low-dose steroid treatment or treatment withdrawal, there is a high incidence of AIP recurrence (24–52%). Therefore, there is a need for long-term steroid maintenance therapy and/or steroid-sparing agents (immunomodulators and rituximab). Corticosteroids play a critical role in the diagnosis and treatment of AIP.

11 August 2021 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
YKYoshihiro Kishida
Yoshihiro Kishida
KTKOHEI TAKIZAWA
KOHEI TAKIZAWA
NKNaomi Kakushima
Naomi Kakushima
NKNoboru Kawata
Noboru Kawata
MYMasao Yoshida
Masao Yoshida
HOHiroyuki Ono
Hiroyuki Ono

25 February 2023 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
SSSeitaro Shimada
Seitaro Shimada
YYYohei Yabuuchi
Yohei Yabuuchi
NKNoboru Kawata
Noboru Kawata
YMYuki Maeda
Yuki Maeda
MYMasao Yoshida
Masao Yoshida
HOHiroyuki Ono
Hiroyuki Ono

28 December 2019 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
KIKenichiro Imai
Kenichiro Imai
KHKinichi Hotta
Kinichi Hotta
SISayo Ito
Sayo Ito
YYYuichiro Yamaguchi
Yuichiro Yamaguchi
YKYoshihiro Kishida
Yoshihiro Kishida
HOHiroyuki Ono
Hiroyuki Ono

30 November 2020 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
NKNaomi Kakushima
Naomi Kakushima
MYMasao Yoshida
Masao Yoshida
YYYohei Yabuuchi
Yohei Yabuuchi
NKNoboru Kawata
Noboru Kawata
KTKOHEI TAKIZAWA
KOHEI TAKIZAWA
HOHiroyuki Ono
Hiroyuki Ono
Prediction of histology by endoscopic examination is important in the clinical management of non-ampullary duodenal epithelial tumors (NADETs), including adenoma and adenocarcinoma. The use of a simple scoring system based on the findings of white-light endoscopy or magnified endoscopy with narrow-band imaging is useful to differentiate between Vienna category 3 (C3) and C4/5 lesions. Less invasive endoscopic resection procedures, such as cold snare polypectomy, are quick to perform and convenient for small (<10 mm) C3 lesions. Neoplasms with higher grade histology, such as C4/5 lesions, should be treated by endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), or surgery. Although EMR often requires piecemeal resection, the complication rate is acceptable. Excellent complete resection rates could be achieved by ESD; however, it remains a challenging method considering the high risk of complications. Shielding or closure of the ulcer after ESD is effective at decreasing the risk of delayed bleeding and perforation. Laparoscopic endoscopic cooperative surgery is an ideal treatment with a high rate of en bloc resection and a low rate of complications, although it is limited to high-volume centers. Patients with NADETs could benefit from a multidisciplinary approach to stratify the optimal treatment based on endoscopic diagnoses.